Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2004

View Archived Issues

Caspases involved in immune thrombocytopenia

A triple TCR peptide vaccine shows promise in patients with multiple sclerosis

Novel CDK inhibitors from BMS show in vivo anticancer activity

Prous Science announces publication of a comprehensive review on insomnia

Shipment of Xifaxan under way

Conditional expansion of Sepracor and Aventis eszopiclone agreement

Nuvelo closes phase II alfimeprase study early

Spheramine granted fast track status for advanced Parkinson's disease

Potent glycogen synthase kinase-3beta inhibitors effective in vivo

Anti-CCR5 monoclonal antibody PRO-140 controls HIV-1 replication in vivo

CCR5 antagonist with potent anti-HIV activity in vitro

Genistein induces apoptosis in HIV-infected cells in vitro

Combination treatment with olive oil extract effective against HIV

Amarin to acquire Laxdale

Rotigotine reduces RLS symptoms in phase IIb trial

Bayer extends support for study in prophylactic treatment of hemophilia A

Cellegy and Strakan enter European commercialization agreement for Tostrex

EnVivo and MethylGene to develop isotypic HDAC inhibitors

PTC-124 enters phase I for cystic fibrosis and Duchenne muscular dystrophy

Initiation of final pivotal phase III study of doripenem for VAP

CLIA waiver for Uni-Gold Recombigen HIV test

Posaconazole NDA accepted for review

Phenomix and Genentech establish collaboration for immune disorders

Inhibitors of kinases claimed by Schering AG

Indolyl derivatives claimed by Roche

Silicon compounds for the treatment of cancer reported by Amedis

Active Biotech describes CD80 antagonists

Selective COX-2 inhibitors described by researchers at CJ Corporation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...